CAREDX, INC. Lease, Cost
CAREDX, INC. (CDNA) reported Lease, Cost of $7.34 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-25
- CAREDX, INC. lease, cost for the quarter ending 2025-03-31 was $1.83M, a 7.31% decline year-over-year.
- CAREDX, INC. lease, cost for the quarter ending 2024-12-31 was $1.82M, a 8.80% decline year-over-year.
- CAREDX, INC. lease, cost for the quarter ending 2024-09-30 was $1.96M, a 1.21% decline year-over-year.
- CAREDX, INC. lease, cost for the quarter ending 2024-06-30 was $1.97M, a 0.35% decline year-over-year.
- CAREDX, INC. lease, cost for fiscal 2025 was $7.34M, a 4.89% decline from fiscal 2024.
- CAREDX, INC. lease, cost for fiscal 2024 was $7.72M, a 2.76% decline from fiscal 2023.
- CAREDX, INC. lease, cost for fiscal 2023 was $7.94M, a 18.17% increase from fiscal 2022.
- CAREDX, INC. lease, cost for fiscal 2022 was $6.72M, a 29.48% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $7.34M 10-K · filed 2026-02-25 | |||
| 2025-03-31 | $1.83M 10-Q · filed 2025-04-30 | $3.65M derived: sum of 2 quarters · filed 2026-02-25 | $5.61M derived: sum of 3 quarters · filed 2026-02-25 | $7.57M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.78M derived: sum of 2 quarters · filed 2026-02-25 | $5.75M derived: sum of 3 quarters · filed 2026-02-25 | $7.72M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.96M 10-Q · filed 2024-11-04 | $3.92M derived: sum of 2 quarters · filed 2024-11-04 | $5.89M 10-Q · filed 2024-11-04 | $7.89M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $1.97M 10-Q · filed 2024-07-31 | $3.94M 10-Q · filed 2024-07-31 | $5.94M derived: sum of 3 quarters · filed 2026-02-25 | $7.92M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.97M 10-Q · filed 2025-04-30 | $3.97M derived: sum of 2 quarters · filed 2026-02-25 | $5.95M derived: sum of 3 quarters · filed 2026-02-25 | $7.92M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.98M derived: sum of 2 quarters · filed 2026-02-25 | $5.95M derived: sum of 3 quarters · filed 2026-02-25 | $7.94M 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.98M 10-Q · filed 2024-11-04 | $3.95M derived: sum of 2 quarters · filed 2024-11-04 | $5.94M 10-Q · filed 2024-11-04 | $7.91M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $1.97M 10-Q · filed 2024-07-31 | $3.96M 10-Q · filed 2024-07-31 | $5.93M derived: sum of 3 quarters · filed 2025-02-28 | $7.89M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $1.98M 10-Q · filed 2024-05-09 | $3.96M derived: sum of 2 quarters · filed 2025-02-28 | $5.91M derived: sum of 3 quarters · filed 2025-02-28 | $7.29M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.93M derived: sum of 2 quarters · filed 2025-02-28 | $5.30M derived: sum of 3 quarters · filed 2025-02-28 | $6.72M 10-K · filed 2025-02-28 |
| 2022-09-30 | $1.96M 10-Q · filed 2023-11-08 | $3.33M derived: sum of 2 quarters · filed 2023-11-08 | $4.74M 10-Q · filed 2023-11-08 | $6.12M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.37M 10-Q · filed 2023-08-08 | $2.79M 10-Q · filed 2023-08-08 | $4.16M derived: sum of 3 quarters · filed 2024-02-28 | $5.51M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $1.41M 10-Q · filed 2023-05-10 | $2.79M derived: sum of 2 quarters · filed 2024-02-28 | $4.13M derived: sum of 3 quarters · filed 2024-02-28 | $5.37M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.72M derived: sum of 2 quarters · filed 2024-02-28 | $3.95M derived: sum of 3 quarters · filed 2024-02-28 | $5.19M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.34M 10-Q · filed 2022-11-03 | $2.58M derived: sum of 2 quarters · filed 2022-11-03 | $3.81M 10-Q · filed 2022-11-03 | $4.95M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $1.23M 10-Q · filed 2022-08-04 | $2.46M 10-Q · filed 2022-08-04 | $3.60M derived: sum of 3 quarters · filed 2023-02-27 | $4.77M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $1.24M 10-Q · filed 2022-05-05 | $2.37M derived: sum of 2 quarters · filed 2023-02-27 | $3.54M derived: sum of 3 quarters · filed 2023-02-27 | $4.71M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $2.31M derived: sum of 2 quarters · filed 2023-02-27 | $3.47M derived: sum of 3 quarters · filed 2023-02-27 | $4.65M 10-K · filed 2023-02-27 |
| 2020-09-30 | $1.17M 10-Q · filed 2021-10-28 | $2.34M derived: sum of 2 quarters · filed 2021-10-28 | $3.51M 10-Q · filed 2021-10-28 | $4.20M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $1.17M 10-Q · filed 2021-07-29 | $2.34M 10-Q · filed 2021-07-29 | $3.03M derived: sum of 3 quarters · filed 2022-02-24 | $3.53M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $1.17M 10-Q · filed 2021-05-05 | $1.86M derived: sum of 2 quarters · filed 2022-02-24 | $2.37M derived: sum of 3 quarters · filed 2022-02-24 | $2.88M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $689.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.20M derived: sum of 2 quarters · filed 2022-02-24 | $1.71M derived: sum of 3 quarters · filed 2022-02-24 | $2.21M 10-K · filed 2022-02-24 |
| 2019-09-30 | $507.00K 10-Q · filed 2020-10-29 | $1.02M derived: sum of 2 quarters · filed 2020-10-29 | $1.52M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $510.00K 10-Q · filed 2020-08-04 | $1.01M 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $491.00K 10-Q · filed 2020-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |